Sherene Loi
谢伦·洛伊
MBBS (Hons), PhD, FRACP
Professor and Head, Translational Breast Cancer Genomics and Immunology Lab转化乳腺癌基因组学与免疫学实验室教授及主任
👥Biography 个人简介
World-leading translational researcher at Peter MacCallum Cancer Centre, pioneering tumor infiltrating lymphocyte (TIL) scoring as a prognostic and predictive biomarker in TNBC and HER2+ breast cancer, enabling precision immunotherapy selection.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Tumor Infiltrating Lymphocytes in Breast Cancer
Established TIL scoring as a validated biomarker for prognosis and immunotherapy response in TNBC, co-developing international guidelines for TIL assessment now used in clinical practice worldwide.
Representative Works 代表性著作
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Journal of Clinical Oncology (2019)
Pooled analysis establishing TIL levels as independent prognostic factor for TNBC, showing each 10% TIL increase associated with improved survival.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 谢伦·洛伊 的研究动态
Follow Sherene Loi's research updates
留下邮箱，当我们发布与 Sherene Loi（Peter MacCallum Cancer Centre, University of Melbourne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment